Polymorphisms of interferon-γ, interleukin-10, and interleukin-12 genes in myasthenia gravis

Human Immunology

Volumn 68, Issue 6, 2007, Pages 544-549

  Yilmaz, Vuslat ^a   Tütüncü, Yildiz ^a   Baris Hasbal N ^a   Parman, Yesim ^b   Serdaroglu, Piraye ^a   Deymeer, Feza ^a   Saruhan Direskeneli, Güher ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b NONE

Author keywords

IFN ; IL 10; IL 12; Myasthenia gravis; Polymorphism

Indexed keywords

CHOLINERGIC RECEPTOR; CONNECTIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THYMOMA;

ALLELES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 34248174458     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2007.02.003     Document Type: Article

References (42)

1. Vincent A., Bowen J., Newsom-Davis J., and McConville J. Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets. Lancet Neurology 2 (2003) 99
2. Drachman D.B. Myasthenia gravis. N Engl J Med 330 (1994) 1797
3. Lindstrom J., Seybold M.E., Lennon V.A., Whittingham S., and Duane D.D. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology 26 (1976) 1054
4. Vincent A., Palace J., and Hilton-Jones D. Myasthenia gravis. Lancet 357 (2001) 2122
5. Hoch W., McConville J., Helms S., Newsom-Davis J., Melms A., and Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 7 (2001) 365
6. Yamamoto A., Gajdos P., Eymard B., Tranchant C., Warter J.M., Gomez L., Bourquin C., Bach J.F., and Garchon H.J. Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients. Arch Neurol 58 (2001) 885
7. Garchon H.-J. Genetics of autoimmune myasthenia gravis, a model for antibody-mediated autoimmunity in man. J Autoimmun 21 (2003) 105
8. Skeie G.O., Bentsen P.T., Freiburg A., Aarli J.A., and Gilhus N.E. Cell-mediated immune response against titin in myasthenia gravis: evidence for the involvement of Th1 and Th2 cells. Scand J Immunol 47 (1998) 76
9. Zhang G.-X., Navikas V., and Link H. Cytokines and the pathogenesis of myasthenia gravis. Muscle Nerve 20 (1997) 543
10. Karachunski P.I., Ostlie N.S., Monfardini C., and Conti-Fine B.M. Absence of IFN-γ or IL-12 has different effects on experimental myasthenia gravis in C57BL/6 mice. J Immunol 164 (2000) 5236
11. Seegers D., Zwiers A., Strober W., Pena A.S., and Bouma G. A Taq I polymorphism in the 3′UTR of the IL-12 p40 gene correlates with increased IL-12 secretion. Genes Immun 3 (2002) 419
12. YIlmaz V., Yentur S.P., and Saruhan-Direskeneli G. IL-12 and IL-10 polymorphisms and their effects on cytokine production. Cytokine 30 (2005) 188
13. Pravica V., Asderakis A., Perrey C., Hajeer A., Sinnott P.J., and Hutchinson I.V. In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet 26 (1999) 1
14. Pravica V., Perrey C., Stevens A., Lee J.H., and Hutchinson I.V. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-γ production. Hum Immunol 61 (2000) 863
15. Crawley E., Kay R., Sillibourne J., Patel P., Hutchinson I., and Woo P. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 42 (1999) 1101
16. Gibson A.W., Edberg J.C., Wu J., Westendorp R.G., Huizinga T.W., and Kimberly R.P. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 166 (2001) 3915
17. Turner D.M., Williams D.M., Sankaran D., Lazarus M., Sinnott P.J., and Hutchinson I.V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24 (1997) 1
18. Vandiedonck C., Giraud M., and Garchon H.-J. Genetics of autoimmune myasthenia gravis: The multifaceted contribution of the HLA complex. J Autoimmun 25 Suppl 1 (2005) 6
19. Saruhan-Direskeneli G., Kilic A., Parman Y., Serdaroglu P., and Deymeer F. HLA-DQ Polymorphism in Turkish patients with myasthenia gravis. Hum Immunol 67 (2006) 352
20. Giraud M., Beaurain G., Yamamoto M.A., Eymard B., Tranchant C., Gajdos P., and Garchon J.H. Linkage of HLA to myasthenia gravis and genetic heterogeneity depending on anti-titin antibodies. Neurology 57 (2001) 1555
21. Romi F., Gilhus N.E., and Aarli J.A. Myasthenia gravis: clinical, immunological, and therapeutic advances. Act Neurol Scand 111 (2005) 134
22. Sciacca F.L., Ferri C., Veglia F., Andreetta F., Mantegazza R., Cornelio F., Franciotta D., Piccolo G., Cosi V., and Batocchi A.P. IL-1 genes in myasthenia gravis: IL-1A -889 polymorphism associated with sex and age of disease onset. J Neuroimmunol 122 (2002) 94
23. Huang D.R., Pirskanen R., Matell G., and Lefvert A.K. Tumour necrosis factor-alpha polymorphism and secretion in myasthenia gravis. J Neuroimmunol 94 (1999) 165
24. Huang D., Pirskanen R., Hjelmstrom P., and Lefvert A.K. Polymorphisms in IL-1beta and IL-1 receptor antagonist genes are associated with myasthenia gravis. J Neuroimmunol 81 (1998) 76
25. Huang D., Liu L., Noren K., Xia S.Q., Trifunovic J., Pirskanen R., and Lefvert A.K. Genetic association of Ctla-4 to myasthenia gravis with thymoma. J Neuroimmunol 88 (1998) 192
26. Chuang W.-Y., Ströbel P., Gold R., Nix W., Schalke B., Kiefer R., Opitz A., Klinker E., Müller-Hermelink H.-K., and Marx A. A CTLA4high genotype is associated with myasthenia gravis in thymoma patients. Ann Neurol 58 (2005) 644
27. Skeie G.O., Pandey J.P., Aarli J.A., and Gilhus N.E. TNFα and TNFβ polymorphisms in myasthenia gravis. Arch Neurol 56 (1999) 457
28. Huang D., Zhou Y., Xia S., Liu L., Pirskanen R., and Lefvert A.K. Markers in the promoter region of interleukin-10 (IL-10) gene in myasthenia gravis: implications of diverse effects of IL-10 in the pathogenesis of the disease. J Neuroimmunol 94 (1999) 82
29. Huang D., Xia S., Zhou Y., Pirskanen R., Liu L., and Lefvert A.K. No evidence for interleukin-4 gene conferring susceptibility to myasthenia gravis. J Neuroimmunol 92 (1998) 208
30. Huang D., Zheng C., Giscombe R., Matell G., Pirskanen R., and Kari Lefvert A. Polymorphisms at -174 and in the 3′-flanking region of interleukin-6 (IL-6) gene in patients with myasthenia gravis. J Neuroimmunol 101 (1999) 197
31. Jaretzki III A., Barohn R.J., Ernstoff R.M., Kaminski H.J., Keesey J.C., Penn A.S., Sanders D.B., and Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Myasthenia gravis: recommendations for clinical research standards. Neurology 55 (2000) 16
32. Huang D., Cancilla M.R., and Morahan G. Complete primary structure, chromosomal localisation, and definition of polymorphisms of the gene encoding the human interleukin-12 p40 subunit. Genes Immun 1 (2000) 515
33. Moiola L., Galbiati F., Martino G., Amadio S., Brambilla E., Comi G., Vincent A., Grimaldi L.M., and Adorini L. IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease. Eur J Immunol 28 (1998) 2487
34. Balasa B., Deng C., Lee J., Bradley L.M., Dalton D.K., Christadoss P., and Sarvetnick N. Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice. J Exp Med 186 (1997) 385
35. Yi Q., Ahlberg R., Pirskanen R., and Lefvert A. Acetylcholine receptor-reactive T cells in myasthenia gravis: evidence for the involvement of different subpopulations of T helper cells. J Neuroimmunol 50 (1994) 177
36. Rossouw M., Nel H.J., Cooke G.S., van Helden P.D., and Hoal E.G. Association between tuberculosis and a polymorphic NFκ B binding site in the interferon gamma gene. Lancet 361 (2003) 1871
37. Hall M.A., McGlinn E., Coakley G., Fisher S.A., Boki K., Middleton D., Kaklamani E., Moutsopoulos H., Loughran Jr. T.P., Ollier W.E., Panayi G.S., and Lanchbury J.S. Genetic polymorphism of IL-12 p40 gene in immune-mediated disease. Genes Immun 1 (2000) 219
38. Ostlie N.S., Karachunski P.I., Wang W., Monfardini C., Kronenberg M., and Conti-Fine B.M. Transgenic expression of IL-10 in T cells facilitates development of experimental myasthenia gravis. J Immunol 166 (2001) 4853
39. Zhang G.-X., Xiao B.-G., Yu L.-Y., van der Meide P.H., and Link H. Interleukin 10 aggravates experimental autoimmune myasthenia gravis through inducing Th2 and B cell responses to AChR. J Neuroimmunol 113 (2001) 10
40. Eskdale J., McNicholl J., Wordsworth P., Jonas B., Huizinga T., Field M., and Gallagher G. Interleukin-10 microsatellite polymorphisms and IL-10 locus alleles in rheumatoid arthritis susceptibility. Lancet 352 (1998) 1282
41. Djabiri F., Caillat-Zucman S., Gajdos P., Jais J.P., Gomez L., Khalil I., Charron D., Bach J.F., and Garchon H.J. Association of the AChRα-subunit gene (CHRNA), DQA1*0101, and the DR3 haplotype in myasthenia gravis. Evidence for a three-gene disease model in a subgroup of patients. J Autoimmun 10 (1997) 407
42. Giraud M., Beaurain G., Eymard B., Tranchant C., Gajdos P., and Garchon H.J. Genetic control of autoantibody expression in autoimmune myasthenia gravis: role of the self-antigen and of HLA-linked loci. Genes Immun 5 (2004) 398